Evidence map›Paper›PMID 26817708›Full record

ArticleBMC genomics2016

Medoidshift clustering applied to genomic bulk tumor data.

Theodore Roman, Lu Xie, Russell Schwartz

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Phylogenetic Copy-Number Factorization of Multiple Tumor Samples.Journal of computational biology : a journal of computational molecular cell biology · 2018
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Theodore RomanComputational Biology Department, School of Computer Science, Carnegie Mellon University, 5000 Forbes Ave, Pittsburgh, 15213, PA, USA. troman@andrew.cmu.edu.
Lu XieComputational Biology Department, School of Computer Science, Carnegie Mellon University, 5000 Forbes Ave, Pittsburgh, 15213, PA, USA. lxie1@andrew.cmu.edu.
Russell SchwartzComputational Biology Department, School of Computer Science, Carnegie Mellon University, 5000 Forbes Ave, Pittsburgh, 15213, PA, USA. russells@andrew.cmu.edu.
Carnegie Mellon University · US

Funding

Integrated Interdisciplinary, inter-university PhD Program Computational Biology (T32)T32EB009403 · NIBIB · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BAHAR, IVET, BAR-JOSEPH, ZIV · 2009 to 2023
$4.4M
Heterogeneous Cancer Progression from Microarray DataR01CA140214 · NCI · CARNEGIE-MELLON UNIVERSITY · PI SCHWARTZ, RUSSELL S · 2009 to 2013
$1.4M
Inferring in vivo Capsid Assembly Kinetics from in vitro by Stochastic SimulationR01AI076318 · NIAID · CARNEGIE-MELLON UNIVERSITY · PI SCHWARTZ, RUSSELL S · 2009 to 2012
$1.1M
NCI NIH HHS 1R01CA140214NCI NIH HHS R01 CA140214NIAID NIH HHS 1R01AI076318NIAID NIH HHS R01 AI076318NIBIB NIH HHS T32 EB009403NIBIB NIH HHS T32EB009403
6 · The paper itself

Abstract

Despite the enormous medical impact of cancers and intensive study of their biology, detailed characterization of tumor growth and development remains elusive. This difficulty occurs in large part because of enormous heterogeneity in the molecular mechanisms of cancer progression, both tumor-to-tumor and cell-to-cell in single tumors. Advances in genomic technologies, especially at the single-cell level, are improving the situation, but these approaches are held back by limitations of the biotechnologies for gathering genomic data from heterogeneous cell populations and the computational methods for making sense of those data. One popular way to gain the advantages of whole-genome methods without the cost of single-cell genomics has been the use of computational deconvolution (unmixing) methods to reconstruct clonal heterogeneity from bulk genomic data. These methods, too, are limited by the difficulty of inferring genomic profiles of rare or subtly varying clonal subpopulations from bulk data, a problem that can be computationally reduced to that of reconstructing the geometry of point clouds of tumor samples in a genome space. Here, we present a new method to improve that reconstruction by better identifying subspaces corresponding to tumors produced from mixtures of distinct combinations of clonal subpopulations. We develop a nonparametric clustering method based on medoidshift clustering for identifying subgroups of tumors expected to correspond to distinct trajectories of evolutionary progression. We show on synthetic and real tumor copy-number data that this new method substantially improves our ability to resolve discrete tumor subgroups, a key step in the process of accurately deconvolving tumor genomic data and inferring clonal heterogeneity from bulk data.

Indexed as

AlgorithmsCluster AnalysisComparative Genomic HybridizationGene DosageHumansNeoplasms

Identifiers

PMID26817708
PMCPMC4895288
OpenAlexW2238824573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.